Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
REPL | Replimune Group, Inc. | Chief Business Officer | $2.88 M | -$945 K | -24.7% | Sep 11, 2023 |
KYMR | Kymera Therapeutics, Inc. | Director | Jun 18, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|